Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1968 1
1969 2
1970 3
1971 2
1973 2
1974 2
1975 1
1976 4
1977 2
1978 7
1980 8
1981 3
1984 4
1985 5
1986 3
1987 4
1988 6
1989 7
1990 4
1991 4
1992 7
1993 3
1994 9
1995 6
1996 7
1997 4
1998 3
1999 4
2000 4
2001 3
2002 6
2003 2
2004 2
2005 6
2006 6
2007 10
2008 10
2009 6
2010 7
2011 4
2012 2
2013 7
2014 2
2015 5
2016 3
2017 4
2018 4
2019 5
2020 3
2021 4
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

210 results
Results by year
Filters applied: . Clear all
Page 1
IP6K2 predicts favorable clinical outcome of primary breast cancer.
Sandström J, Balian A, Lockowandt R, Fornander T, Nordenskjöld B, Lindström L, Pérez-Tenorio G, Stål O. Sandström J, et al. Among authors: nordenskjold b. Mol Clin Oncol. 2021 May;14(5):94. doi: 10.3892/mco.2021.2256. Epub 2021 Mar 12. Mol Clin Oncol. 2021. PMID: 33767863 Free PMC article.
Swedish Cancer Society radiation therapy research investigation.
Mattsson S, Brahme A, Carlsson J, Denekamp J, Forssell-Aronsson E, Hellström M, Johansson KA, Kjellén E, Littbrand B, Nordenskjöld B, Stenerlöw B, Turesson I, Zackrisson B, Glimelius B; Swedish Cancer Society. Mattsson S, et al. Among authors: nordenskjold b. Acta Oncol. 2002;41(7-8):596-603. Acta Oncol. 2002. PMID: 14651202 Review.
Assessment of Long-term Distant Recurrence-Free Survival Associated With Tamoxifen Therapy in Postmenopausal Patients With Luminal A or Luminal B Breast Cancer.
Yu NY, Iftimi A, Yau C, Tobin NP, van 't Veer L, Hoadley KA, Benz CC, Nordenskjöld B, Fornander T, Stål O, Czene K, Esserman LJ, Lindström LS. Yu NY, et al. Among authors: nordenskjold b. JAMA Oncol. 2019 Sep 1;5(9):1304-1309. doi: 10.1001/jamaoncol.2019.1856. JAMA Oncol. 2019. PMID: 31393518 Free PMC article.
MCM3 upregulation confers endocrine resistance in breast cancer and is a predictive marker of diminished tamoxifen benefit.
Løkkegaard S, Elias D, Alves CL, Bennetzen MV, Lænkholm AV, Bak M, Gjerstorff MF, Johansen LE, Vever H, Bjerre C, Kirkegaard T, Nordenskjöld B, Fornander T, Stål O, Lindström LS, Esserman LJ, Lykkesfeldt AE, Andersen JS, Leth-Larsen R, Ditzel HJ. Løkkegaard S, et al. Among authors: nordenskjold b. NPJ Breast Cancer. 2021 Jan 4;7(1):2. doi: 10.1038/s41523-020-00210-8. NPJ Breast Cancer. 2021. PMID: 33398005 Free PMC article.
Survival patterns of invasive lobular and invasive ductal breast cancer in a large population-based cohort with two decades of follow up.
Chamalidou C, Fohlin H, Albertsson P, Arnesson LG, Einbeigi Z, Holmberg E, Nordenskjöld A, Nordenskjöld B, Karlsson P, Linderholm B; Swedish western and south-eastern breast cancer groups. Chamalidou C, et al. Among authors: nordenskjold b. Breast. 2021 Oct;59:294-300. doi: 10.1016/j.breast.2021.07.011. Epub 2021 Jul 22. Breast. 2021. PMID: 34388695 Free PMC article.
210 results